NPI: 1407818552 · NORTH CHARLESTON, SC 29406 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/04/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 04/04/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 3,162 | $74K |
| 2019 | 9,612 | $208K |
| 2020 | 13,589 | $107K |
| 2021 | 12,444 | $56K |
| 2022 | 8,856 | $61K |
| 2023 | 3,239 | $42K |
| 2024 | 974 | $20K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| A4657 | Syringe, with or without needle, each | 3,305 | 1,660 | $267K |
| 90935 | Hemodialysis procedure with single evaluation by a physician | 21,285 | 2,022 | $228K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 9,285 | 1,347 | $64K |
| J1756 | Injection, iron sucrose, 1 mg | 2,893 | 880 | $5K |
| J1270 | Injection, doxercalciferol, 1 mcg | 9,184 | 1,033 | $1K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 41 | 24 | $978.00 |
| 83970 | 1,168 | 1,033 | $823.21 | |
| 82728 | 512 | 447 | $127.54 | |
| 90674 | 51 | 50 | $126.17 | |
| 83550 | 507 | 444 | $113.49 | |
| 83540 | 522 | 456 | $108.18 | |
| 0001A | 17 | 14 | $92.37 | |
| 0124A | 13 | 13 | $87.50 | |
| 0002A | 15 | 12 | $86.22 | |
| 85041 | 1,373 | 1,205 | $82.44 | |
| 85048 | 1,369 | 1,201 | $79.83 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 254 | 165 | $28.73 |
| 82108 | 47 | 44 | $23.03 | |
| G0008 | Administration of influenza virus vaccine | 35 | 34 | $0.00 |